Literature DB >> 33045939

Paving the way towards a weight-loss intervention study in obese patients with inflammatory bowel disease.

Julien Kirchgesner1.   

Abstract

Entities:  

Year:  2020        PMID： 33045939      PMCID： PMC7724523          DOI： 10.1177/2050640620965113

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  7 in total

1.  Faecal calprotectin levels before and after weight loss in obese and overweight subjects.

Authors:  P Kant; R Fazakerley; M A Hull
Journal:  Int J Obes (Lond)       Date:  2012-03-13       Impact factor: 5.095

Review 2.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Authors:  Siddharth Singh; Parambir S Dulai; Amir Zarrinpar; Sonia Ramamoorthy; William J Sandborn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-30       Impact factor: 46.802

3.  Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.

Authors:  Thomas Greuter; Frédéric Porchet; Manuel B Braga-Neto; Jean-Benoit Rossel; Luc Biedermann; Philipp Schreiner; Michael Scharl; Alain M Schoepfer; Ekaterina Safroneeva; Alex Straumann; Gerhard Rogler; Stephan R Vavricka
Journal:  United European Gastroenterol J       Date:  2020-12       Impact factor: 4.623

4.  Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.

Authors:  Animesh Jain; Nghia H Nguyen; James A Proudfoot; Christopher F Martin; William J Sandborn; Michael D Kappelman; Millie D Long; Siddharth Singh
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

Review 5.  Obesity, inflammation, and atherosclerosis.

Authors:  Viviane Z Rocha; Peter Libby
Journal:  Nat Rev Cardiol       Date:  2009-04-28       Impact factor: 32.419

6.  Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Authors:  Matteo Nicola Dario Di Minno; Rosario Peluso; Salvatore Iervolino; Anna Russolillo; Roberta Lupoli; Raffaele Scarpa
Journal:  Ann Rheum Dis       Date:  2013-06-14       Impact factor: 19.103

Review 7.  Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Authors:  Roberta Lupoli; Paolo Pizzicato; Antonella Scalera; Pasquale Ambrosino; Manuela Amato; Rosario Peluso; Matteo Nicola Dario Di Minno
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156
  7 in total
  1 in total

1.  Burden of obesity in gastrointestinal and liver diseases.

Authors:  Zeljko Krznaric
Journal:  United European Gastroenterol J       Date:  2022-08-31       Impact factor: 6.866
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.